National trends in the mental health care of children, adolescents, and adults by office-based physicians

JAMA Psychiatry

Volumn 71, Issue 1, 2014, Pages 81-90

  Olfson, Mark ^a   Blanco, Carlos ^a   Wang, Shuai ^a   Laje, Gonzalo ^b   Correll, Christoph U ^c,d  

^a Department of Psychiatry College of Physicians and Surgeons Columbia University ^*  (United States)

^b Maryland Institute of Neuroscience and Development   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d North Shore Long Island Jewish Health System Zucker Hillside Hospital ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; MOOD STABILIZER; PSYCHOTROPIC AGENT;

ADOLESCENT; ADULT; ANXIETY DISORDER; ARTICLE; BIPOLAR DISORDER; CHILD; CONTROLLED STUDY; DEPRESSION; DEVELOPMENTAL DISORDER; DISRUPTIVE BEHAVIOR; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; MENTAL DISEASE; MENTAL HEALTH CARE; NEWBORN; OUTPATIENT; PRESCHOOL CHILD; PRESCRIPTION; PSYCHIATRIST; PSYCHOSIS; PSYCHOTHERAPY; SCHOOL CHILD; YOUNG ADULT;

EID: 84892752703     PISSN: 2168622X     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamapsychiatry.2013.3074     Document Type: Article

References (66)

1. Olfson M, Blanco C, Liu SM, Wang S, Correll CU. National trends in the office-based treatment of children, adolescents, and adults with antipsychotics. Arch Gen Psychiatry. 2012;69(12):1247-1256.
2. Vitiello B, Zuvekas SH, Norquist GS. National estimates of antidepressant medication use among U.S. children, 1997-2002. J AmAcad Child Adolesc Psychiatry. 2006;45(3):271-279.
3. Garfield CF, Dorsey ER, Zhu S, et al. Trends in attention deficit hyperactivity disorder ambulatory diagnosis and medical treatment in the United States, 2000-2010. Acad Pediatr. 2012;12(2):110-116.
4. Correll CU, Kratochvil CJ, March JS. Developments in pediatric psychopharmacology: focus on stimulants, antidepressants, and antipsychotics. J Clin Psychiatry. 2011;72(5): 655-670.
5. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 1999;56(12):1073-1086.
6. McCracken JT, McGough J, Shah B, et al; Research Units on Pediatric Psychopharmacology Autism Network. Risperidone in children with autism and serious behavioral problems. N Engl J Med. 2002;347(5):314-321. (Pubitemid 34815353)
7. Tohen M, Kryzhanovskaya L, Carlson G, et al. Olanzapine versus placebo in the treatment of adolescents with bipolar mania. Am J Psychiatry. 2007;164(10):1547-1556. (Pubitemid 350069734)
8. March J, Silva S, Petrycki S, et al; Treatment for Adolescents With Depression Study (TADS) Team. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial. JAMA. 2004;292(7):807-820. (Pubitemid 39079667)
9. Walkup JT, Albano AM, Piacentini J, et al. Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety. N Engl J Med. 2008;359(26):2753-2766.
10. McClellan JM, Werry JS. Evidence-based treatments in child and adolescent psychiatry: an inventory. J AmAcad Child Adolesc Psychiatry. 2003;42(12):1388-1400. (Pubitemid 39585968)
11. Pliszka S; AACAPWork Group on Quality Issues. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/ hyperactivity disorder. J AmAcad Child Adolesc Psychiatry. 2007;46(7):894-921.
12. Volkmar F, Cook EH Jr, Pomeroy J, Realmuto G, Tanguay P; American Academy of Child and Adolescent Psychiatry Working Group on Quality Issues. Practice parameters for the assessment and treatment of children, adolescents, and adults with autism and other pervasive developmental disorders. J AmAcad Child Adolesc Psychiatry. 1999;38(12 suppl):32S-54S.
13. Connolly SD, Bernstein GA;Work Group on Quality Issues. Practice parameter for the assessment and treatment of children and adolescents with anxiety disorders. J AmAcad Child Adolesc Psychiatry. 2007;46(2):267-283.
14. Birmaher B, Brent D, Bernet W, et al; AACAP Work Group on Quality Issues. Practice parameter for the assessment and treatment of children and adolescents with depressive disorders. J AmAcad Child Adolesc Psychiatry. 2007;46(11):1503-1526.
15. Olfson M, Marcus SC. National trends in outpatient psychotherapy. Am J Psychiatry. 2010;167(12):1456-1463.
16. Pescosolido BA, Martin JK, Long JS, Medina TR, Phelan JC, Link BG. "A disease like any other"? a decade of change in public reactions to schizophrenia, depression, and alcohol dependence. Am J Psychiatry. 2010;167(11): 1321-1330.
17. Olfson M, Marcus SC, Druss BG. Effects of Food and Drug Administration warnings on antidepressant use in a national sample. Arch Gen Psychiatry. 2008;65(1):94-101.
18. Libby AM, Orton HD, Valuck RJ. Persisting decline in depression treatment after FDA warnings. Arch Gen Psychiatry. 2009;66(6): 633-639.
19. Valluri S, Zito JM, Safer DJ, Zuckerman IH, Mullins CD, Korelitz JJ. Impact of the 2004 Food and Drug Administration pediatric suicidality warning on antidepressant and psychotherapy treatment for new-onset depression. Med Care. 2010;48(11):947-954.
20. American Diabetes Association; American Psychiatric Association; American Association of Clinical Endocrinologists; North American Association for the Study of Obesity. Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care. 2004;27(2):596-601.
21. Constantine R, Tandon R. Changing trends in pediatric antipsychotic use in Florida's Medicaid program. Psychiatr Serv. 2008;59(10):1162-1168.
22. Rosenberg RE, Daniels AM, Law JK, Law PA, Kaufmann WE. Trends in autism spectrum disorder diagnoses: 1994-2007. J Autism Dev Disord. 2009;39(8):1099-1111.
23. Zuvekas SH, Vitiello B, Norquist GS. Recent trends in stimulant medication use among U.S. children. Am J Psychiatry. 2006;163(4):579-585. (Pubitemid 44464565)
24. Moreno C, Laje G, Blanco C, Jiang H, Schmidt AB, Olfson M. National trends in the outpatient diagnosis and treatment of bipolar disorder in youth. Arch Gen Psychiatry. 2007;64(9):1032-1039. (Pubitemid 47360848)
25. Hsiao CJ, Cherry DK, Beatty PC, Rechtsteiner EA; Centers for Disease Control and Prevention. National Ambulatory Medical Care Survey: 2007 Summary. Hyattsville, MD: National Center for Health Statistics; 2013.
26. US Census Bureau. Population estimates: population and housing unit estimates. US Department of Commerce website. http://www.census.gov/popest/ index.html. Accessed November 1, 2013.
27. Smart DR. Physician Characteristics and Distribution in the US. Chicago, IL: Division of Survey and Data Resources, American Medical Association; 2010.
28. Merikangas KR, He JP, Brody D, Fisher PW, Bourdon K, Koretz DS. Prevalence and treatment of mental disorders among US children in the 2001-2004 NHANES. Pediatrics. 2010;125(1):75-81.
29. Merikangas KR, He JP, Burstein M, et al. Service utilization for lifetime mental disorders in U.S. adolescents: results of the National Comorbidity Survey-Adolescent Supplement (NCS-A). J AmAcad Child Adolesc Psychiatry. 2011;50(1):32-45.
30. Thomas CR, Holzer CE III. The continuing shortage of child and adolescent psychiatrists. J AmAcad Child Adolesc Psychiatry. 2006;45(9):1023-1031. (Pubitemid 44348741)
31. Stein RE, Horwitz SM, Storfer-Isser A, Heneghan A, Olson L, Hoagwood KE. Do pediatricians think they are responsible for identification and management of child mental health problems? results of the AAP periodic survey. Ambul Pediatr. 2008;8(1):11-17.
32. Heneghan A, Garner AS, Storfer-Isser A, Kortepeter K, Stein REK, Horwitz SM. Pediatricians' role in providing mental health care for children and adolescents: do pediatricians and child and adolescent psychiatrists agree? J Dev Behav Pediatr. 2008;29(4):262-269.
33. Ross WJ, Chan E, Harris SK, Goldman SJ, Rappaport LA. Pediatrician-psychiatrist collaboration to care for children with attention deficit hyperactivity disorder, depression, and anxiety. Clin Pediatr (Phila). 2011;50(1):37-43.
34. Kuehn BM. Pediatrician-psychiatrist partnerships expand access to mental health care. JAMA. 2011;306(14):1531-1533.
35. Sarvet B, Gold J, Bostic JQ, et al. Improving access to mental health care for children: the Massachusetts Child Psychiatry Access Project. Pediatrics. 2010;126(6):1191-1200.
36. Children and Adults with Attention Deficit/Hyperactivity-Disorder (CHADD): State Advocacy Toolkit 2011. CHADD website. http://www.chadd.org/ Advocacy/State-Advocacy-Toolkit.aspx#.UnQRFRDgeeA. Accessed January 18, 2013.
37. Pliszka SR, Lopez M, Crismon ML, et al. A feasibility study of the children's medication algorithm project (CMAP) algorithm for the treatment of ADHD. J AmAcad Child Adolesc Psychiatry. 2003;42(3):279-287. (Pubitemid 39592083)
38. Kroutil LA, Van Brunt DL, Herman-Stahl MA, Heller DC, Bray RM, Penne MA. Nonmedical use of prescription stimulants in the United States. Drug Alcohol Depend. 2006;84(2):135-143. (Pubitemid 44160579)
39. McCabe SE, Cranford JA, Boyd CJ. The relationship between past-year drinking behaviors and nonmedical use of prescription drugs: prevalence of co-occurrence in a national sample. Drug Alcohol Depend. 2006;84(3):281-288. (Pubitemid 44287216)
40. Kollins SH. Abuse liability of medications used to treat attention-deficit/hyperactivity disorder (ADHD). AmJ Addict. 2007;16(suppl 1):35-42; quiz 43-44.
41. Merikangas KR, He JP, Rapoport J, Vitiello B, Olfson M. Medication use in US youth with mental disorders. JAMA Pediatr. 2013;167(2):141-148.
42. Alexander GC, Gallagher SA, Mascola A, Moloney RM, Stafford RS. Increasing off-label use of antipsychotic medications in the United States, 1995-2008. Pharmacoepidemiol Drug Saf. 2011;20(2):177-184.
43. Kutcher S, Aman M, Brooks SJ, et al. International consensus statement on attention-deficit/hyperactivity disorder (ADHD) and disruptive behaviour disorders (DBDs): clinical implications and treatment practice suggestions. Eur Neuropsychopharmacol. 2004;14(1):11-28. (Pubitemid 37495027)
44. Scotto Rosato N, Correll CU, Pappadopulos E, Chait A, Crystal S, Jensen PS; Treatment of Maladaptive Aggressive in Youth Steering Committee. Treatment of maladaptive aggression in youth: CERT guidelines II: treatments and ongoing management. Pediatrics. 2012;129(6):e1577-e1586.
45. Correll CU, Lencz T, Malhotra AK. Antipsychotic drugs and obesity. Trends Mol Med. 2011;17(2):97-107.
46. Correll CU. Antipsychotic use in children and adolescents: minimizing adverse effects to maximize outcomes. J AmAcad Child Adolesc Psychiatry. 2008;47(1):9-20.
47. Fortney JC, Pyne JM, Mouden SB, et al. Practice-based versus telemedicine-based collaborative care for depression in rural federally qualified health centers: a pragmatic randomized comparative effectiveness trial. Am J Psychiatry. 2013;170(4):414-425.
48. Mojtabai R. Americans' attitudes toward psychiatric medications: 1998-2006. Psychiatr Serv. 2009;60(8):1015-1023.
49. Mojtabai R. Americans' attitudes toward mental health treatment seeking: 1990-2003. Psychiatr Serv. 2007;58(5):642-651. (Pubitemid 46841886)
50. Wang PS, Simon GE, Avorn J, et al. Telephone screening, outreach, and care management for depressed workers and impact on clinical and work productivity outcomes: a randomized controlled trial. JAMA. 2007;298(12):1401- 1411. (Pubitemid 47481606)
51. Belnap BH, Kuebler J, Upshur C, et al. Challenges of implementing depression care management in the primary care setting. Adm Policy Ment Health. 2006;33(1):65-75.
52. Myette TL. Integrated management of depression: improving system quality and creating effective interfaces. J Occup Environ Med. 2008;50(4):482-491. (Pubitemid 351521623)
53. Eyberg SM, Nelson MM, Boggs SR. Evidence-based psychosocial treatments for children and adolescents with disruptive behavior. J Clin Child Adolesc Psychol. 2008;37(1):215-237.
54. David-Ferdon C, Kaslow NJ. Evidence-based psychosocial treatments for child and adolescent depression. J Clin Child Adolesc Psychol. 2008;37(1):62-104.
55. Silverman WK, Pina AA, Viswesvaran C. Evidence-based psychosocial treatments for phobic and anxiety disorders in children and adolescents. J Clin Child Adolesc Psychol. 2008;37(1):105-130.
56. Mojtabai R, Olfson M. National trends in psychotherapy by office-based psychiatrists. Arch Gen Psychiatry. 2008;65(8):962-970.
57. Frick PJ, Lahey BB, Applegate B, et al. DSM-IV field trials for the disruptive behavior disorders: symptom utility estimates. J AmAcad Child Adolesc Psychiatry. 1994;33(4):529-539. (Pubitemid 24133072)
58. Kessler RC, Berglund P, Demler O, et al; National Comorbidity Survey Replication. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003;289(23):3095-3105. (Pubitemid 37432885)
59. McLean CP, Asnaani A, Litz BT, Hofmann SG. Gender differences in anxiety disorders: prevalence, course of illness, comorbidity and burden of illness. J Psychiatr Res. 2011;45(8):1027-1035.
60. Nguyen L, Huang LN, Arganza GF, Liao Q. The influence of race and ethnicity on psychiatric diagnoses and clinical characteristics of children and adolescents in children's services. Cultur Divers EthnicMinor Psychol. 2007;13(1):18-25. (Pubitemid 46106968)
61. Yeh M, McCabe K, Hurlburt M, et al. Referral sources, diagnoses, and service types of youth in public outpatient mental health care: a focus on ethnicminorities. J Behav Health Serv Res. 2002;29(1):45-60. (Pubitemid 34150319)
62. Rust G, Baltrus P, Ye J, et al. Presence of a community health center and uninsured emergency department visit rates in rural counties. J Rural Health. 2009;25(1):8-16.
63. Correll CU, Sheridan EM, DelBello MP. Antipsychotic and mood stabilizer efficacy and tolerability in pediatric and adult patients with bipolar I mania: a comparative analysis of acute, randomized, placebo-controlled trials. Bipolar Disord. 2010;12(2):116-141.
64. Dusetzina SB, Gaynes BN, Weinberger M, Farley JF, Sleath B, Hansen RA. Receipt of guideline-concordant pharmacotherapy among children with new diagnoses of bipolar disorder. Psychiatr Serv. 2011;62(12):1443-1449.
65. Zima BT, Bussing R, Tang L, et al. Quality of care for childhood attention-deficit/hyperactivity disorder in amanaged care Medicaid program. J AmAcadChild Adolesc Psychiatry. 2010;49(12):1225-1237.e1-11.
66. Kolko DJ, Campo JV, Kelleher K, Cheng Y. Improving access to care and clinical outcome for pediatric behavioral problems: a randomized trial of a nurse-administered intervention in primary care. J Dev Behav Pediatr. 2010;31(5):393-404.